References
- Shojaei A. H. Buccal mucosa as a route for systemic drug delivery: a review. J. Pharm. Pharm. Sci. 1998; 1(1)15–30, [PUBMED], [INFOTRIEVE], [CSA]
- Khanna R., Agarwal S. P., Ahuja A. Mucoadhesive buccal drug delivery: a potential alternative to conventional therapy. Indian J. Pharm. Sci. 1998; 60(1)1–11
- Junginger H. E. Mucoadhesive hydrogels. Pharm. Ind. 1991; 53(11)1056–1065
- Jacques Y., Buri P. An investigation of the physical behavior of moisture‐activated mucoadhesive hydrogels upon contact with biological and non‐biological substrates. Pharm. Acta. Helv. 1997; 72: 225–232, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Smart J. D. An in‐vitro assessment of some mucosa‐adhesive dosage forms. Int. J. Pharm. 1991; 73: 69–74, [CROSSREF]
- Mortazavi S. A., Smart J. D. An investigation of some factors influencing the in‐vitro assessment of mucoadhesion. Int. J. Pharm. 1995; 116: 223–230, [CROSSREF]
- Sungthongjeen S., Pitaksuteepong T., Somsiri A., Sriamornsak P. Studies on pectins as potential hydrogel matrices for controlled release drug delivery. Drug Dev. Ind. Pharm. 1999; 25(12)1271–1276, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Illeum L. Chitosan and its use as a pharmaceutical excipient. Pharm. Res. 1998; 15(9)1326–1331, [CROSSREF]
- Rao K. V.R., Buri P. A novel in‐situ method to test polymers and coated microparticles for bioadhesion. Int. J. Pharm. 1989; 52: 265–270, [CROSSREF]
- Nafee N. A., Ismail F. A., Boraie N. A., Mortada L. M. Design and characterization of mucoadhesive buccal patches containing cetylpyridinium chloride. Acta Pharm. 2003; 53: 199–212, [PUBMED], [INFOTRIEVE]
- Wong C. F., Yuen K. H., Peh K. K. An in‐vitro method for buccal adhesion studies: importance of instrument variables. Int. J. Pharm. 1999; 180(1)47–57, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Anlar S., Capan Y., Hincal A. Physico–chemical and bioadhesive properties of polyacrylic acid polymers. Pharmazie 1993; 48: 285–287, [PUBMED], [INFOTRIEVE]
- Mortazavi S. A., Smart J. D. Factors influencing gel strengthening at the mucoadhesive‐mucus interface. J. Pharm. Pharmacol. 1994; 46: 86–90, [PUBMED], [INFOTRIEVE]
- Kristmundsdottir T., Ingvarsdottir K., Saemundsdottir G. Chitosan matrix tablets: the influence of excipients on drug release. Drug Dev. Ind. Pharm. 1995; 21(13)1591–1598
- Mortazavi S. A., Smart J. D. An in‐vitro method for assessing the duration of mucoadhesion. J. Control. Release 1994; 31: 207–212, [CROSSREF]
- Fabregas J. L., Garcia N. In‐vitro studies on buccoadhesive tablet formulations of hydrocortisone hemisuccinate. Drug Dev. Ind. Pharm. 1995; 21(14)1689–1696
- Parodi B., Russo E., Caviglioli G., Cafaggi S., Bignardi G. Development and characterization of a buccoadhesive dosage form of oxycodone hydrochloride. Drug Dev. Ind. Pharm. 1996; 22(5)445–450
- Bottenberg P., Cleymaet R., De Muynck C., Remon J. P., Coomans D., Michotte Y. Development and testing of bioadhesive fluoride containing slow release tablets for oral use. J. Pharm. Pharmacol. 1991; 43: 457–464, [PUBMED], [INFOTRIEVE]
- Agarwal V., Mishra B. Design, development, and biopharmaceutical properties of buccoadhesive compacts of pentazocine. Drug Dev. Ind. Pharm. 1999; 25(6)701–709, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tobyn M. J., Johnson J. R., Dttmar P. W. Factors affecting in‐vitro gastric mucoadhesion. IV. Influence of tablet excipients, surfactants, and salts on the observed mucoadhesion of polymers. Eur. J. Pharm. Biopharm. 1997; 43: 65–71, [CROSSREF]
- Garcia‐Gonzalez N., Blanco‐Fuente H., Igea S., Delgado‐Charro B., Otero‐Espinar F. J., Blanco‐Mendez J. In‐vitro characterization of bioadhesive metoclopramide tablets for buccal application prepared with poly (acrylic acid) and hydroxypropylmethyl cellulose. STP Pharma Sci. 1992; 2(6)494–499